IngredientsThe coconut tree (Cocos nucifera) is a member of the palm tree family (Arecaceae) and the only living species of the genus Cocos. Botanically speaking, the coconut fruit is a drupe — a fleshy fruit with a hard stone containing the seed — and not a true nut. The name comes from the old Portuguese word coco, meaning "head" or "skull," after the three indentations on the coconut shell that resemble facial features. Originally native to the Central Indo-Pacific, the species is now ubiquitous in coastal tropical regions.
Coconut milk is the aqueous extract of the solid endosperm (kernel) of the coconut. It is a relatively stable oil-in-water emulsion with proteins that act as emulsifiers and thickening agents, and it is opaque and milky white in color, ranging in consistency from watery to creamy. It should not be confused with coconut water, which is the clear liquid found naturally inside the unripe fruit; coconut milk is produced exclusively from the mature, solid endosperm.
Thai cuisine, for example, distinguishes between different thicknesses of coconut milk for specific applications — thick coconut milk for curry bases and desserts, while thinner versions are used for soups and lighter sauces.
The cultivation of coconuts dates back thousands of years, with origins believed to trace to the coastal regions of Southeast Asia and the Pacific Islands. Early civilizations recognized the coconut palm (Cocos nucifera) as a valuable resource, not only for its fruit and oil but also for its medicinal properties. Coconut graters (also called "coconut scrapers"), a necessary tool for traditionally extracting coconut milk, were part of the material culture of the Austronesian peoples. From Island Southeast Asia, the practice was carried along with the sea voyages of the Austronesian expansion, reaching as far as Polynesia in the east and Madagascar and the Comoros in the west in prehistoric times. The technology also spread to non-Austronesian cultures in coastal East Africa by proximity.
In ancient Indian cuisine, coconut milk became integral to South Indian cooking, particularly in coastal regions like Kerala and Tamil Nadu. Traditional recipes for sambar, rasam, and various vegetable preparations relied on coconut milk not just for flavor but as a crucial source of calories and nutrition in predominantly plant-based diets. In Ayurveda, the traditional healing system of India, coconut milk was considered a vital ingredient in numerous medicinal formulations due to its cooling and nourishing properties. It was believed to pacify excess heat and inflammation in the body, making it particularly beneficial for ailments related to Pitta dosha imbalance. In Ayurvedic medicine, the coconut tree is often referred to as the "Kalpavriksha" or the "Tree of Life."
Southeast Asian cultures developed sophisticated techniques for incorporating coconut milk into both sweet and savory dishes. In the Philippines, coconut milk became essential for dishes like adobo, kare-kare, and numerous rice-based desserts that remain popular today. In Sulawesi (Indonesia), a medicinal concoction called sarraba is prepared in coconut milk. It contains palm sugar, ginger, lemongrass, cinnamon, pepper, and egg yolk, and is used as a rejuvenating warm beverage believed to keep the body warm and help cure various types of flu.
In the Pacific Islands, coconut milk is not just a culinary ingredient but a part of cultural identity. Traditional dishes such as 'Palusami' or 'Luau' in Samoa and Tonga, where taro leaves are baked with coconut milk, exhibit the simplicity and purity of island cooking. In Hawaii, 'Haupia,' a coconut milk-based dessert, is a testament to the ingredient's versatility.
In the Caribbean, coconut milk is essential in dishes like 'Rice and Peas' in Jamaica and 'Callaloo' in Trinidad and Tobago. In African countries such as Tanzania and Mozambique, coconut milk is used in aromatic curries and rice dishes, infusing local ingredients with its creamy texture. Arab and Indian traders introduced coconut milk preparation techniques to East Africa and the Middle East. Portuguese and Spanish explorers brought coconuts to the Americas, where indigenous populations adapted the ingredient to local cuisines. In Colombia and Panama, the grated flesh of coconut and coconut milk are used to make sweet titoté, a key ingredient in making arroz con coco (coconut rice).
In Indian and Southeast Asian cultures, chilled coconut milk is consumed traditionally to remedy acidity and stomach ulcers. In many Asian cultures, taking a coconut milk bath is a common practice, as it is believed to help keep the skin soft and supple due to its inherent moisturizing properties. In India, the coconut forms the basis of some Hindu rituals. It is commonly offered to a Hindu god or goddess during worship.
The industrial revolution and improved transportation in the 19th and 20th centuries made coconut milk more widely available beyond tropical regions. Canning technology, developed in the mid-20th century, revolutionized coconut milk distribution by allowing stable, long-term storage and international shipping.
In a 100-milliliter portion, coconut milk contains 230 kilocalories and is 68% water, 24% total fat, 6% carbohydrates, and 2% protein. According to USDA data, it typically contains high fat (~33.5 g/100 g), high carbohydrates (~15.2 g/100 g), moderate sugars (~6.2 g/100 g), and low protein (~3.3 g/100 g). Coconut milk is an emulsion containing mainly lipid, carbohydrates, and proteins. It also contains several minor compounds including phenolic substances.
The fat composition includes 21 grams of saturated fat per 100 ml, half of which is lauric acid. Coconut milk is exceptionally rich in medium-chain fatty acids (MCFAs), particularly lauric acid (C12:0), which accounts for 45–50% of total fat. Other MCFAs, including myristic (C14:0), palmitic (C16:0), caprylic (C8:0), and capric (C10:0) acids, further contribute to its unique lipid composition.
The major saturated fatty acids in coconut fat are lauric (C12), myristic (C14), and palmitic (C15), which together give 72.2% of the total saturated fatty acids in coconut. Coconut fat has only 36.5% (per 100 g of total fat) of fatty acids that could be classified as long chain. Some 45.8% consists of lauric acid, which has a 12-carbon chain.
Both coconut maturity and tissue type significantly influence fatty acid composition. As coconuts develop from tender to mature stages, the total lipid content increases markedly, accompanied by a relative enrichment of MCFAs including lauric, caprylic, and capric acids, and a corresponding reduction in long-chain and unsaturated fatty acids. Consequently, the proportion of saturated fatty acids increases while that of unsaturated fatty acids declines.
Lauric acid (LA), also known as dodecanoic acid, is a saturated fatty acid in coconut oil known for its potential health benefits and biomedical applications. Virgin coconut oil contains lauric acid (45 to 52%). By lipase in the digestive system, it can undergo a breakdown into lauric acid, 1-monolaurin, and 2-monolaurin. These components have both hydrophilic and lipophilic groups and are recognized as excellent antimicrobial lipids. Furthermore, lauric acid and monolaurin can be used as antibacterial, antifungal, and antiviral with broad-spectrum inhibition.
Phenolic compounds are widely considered key contributors to the functional properties of coconut, and their concentration can serve as an important indicator of nutritional and bioactive potential. Results from research indicate that the phenolic compounds of all coconut milk preparations provide protection against oxidative damage on lipids and inhibit oxidative damage of both proteins and DNA. Antioxidant properties evaluated by ferric reducing power (FRAP) assay and 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay indicate that coconut milk displays higher antioxidant properties than cow's milk.
Coconut milk is a rich source (20% or more of the Daily Value) of manganese (40% DV per 100 g), with no other micronutrients in significant content according to USDA data.
Metabolites including ethanol, valine, GABA, arginine, lactic acid, acetoin, alanine, phenylalanine, acetic acid, methionine, acetone, pyruvate, succinic acid, malic acid, tryptophan, uridine, uracil, and cytosine are higher in fermented coconut milk compared to fresh coconut milk, reflecting the biochemical transformations that occur during lactic acid fermentation. Fermentation of coconut milk with L. plantarum has been shown to have high potential benefits for extending shelf life and improving biological activities as well as other beneficial nutrients.
Unlike long-chain fatty acids (LCFAs) predominant in dairy and most plant-based milks, MCFAs are directly absorbed into the portal circulation and rapidly metabolized to acetyl-CoA or ketone bodies. This metabolic pathway bypasses the more complex digestion and transport mechanisms required for LCFAs, enabling faster energy release and potentially contributing to reduced fat accumulation and improved metabolic health.
Medium-chain triglycerides/MCFAs have a favorable safety profile and are used to treat a variety of disorders, including benefits in skin care, weight loss, cholesterol level maintenance, immunomodulatory effects, and cardiovascular uses, and more recently in Alzheimer's disease.
Monolaurin, derived from lauric acid, has been observed to disrupt the lipid membranes of various harmful pathogens — including bacteria, viruses, and fungi — rendering them inactive or less virulent. Lauric acid and monolaurin have a strong ability to destroy gram-positive bacteria, especially S. aureus, fungi such as C. albicans, and viruses including vesicular stomatitis virus (VSV), herpes simplex virus (HSV), and visna virus (VV). The mechanism is understood to involve disruption of the microbial cell membrane or lipid envelope via both hydrogen and hydrophobic interactions.
Phenolic substances of coconut milk may protect macromolecules such as lipids, proteins, and DNA against oxidative damage in living systems. Coconut contains phenols, which are antioxidants. During metabolism and other processes, the body produces waste products called reactive oxygen species, or free radicals. Free radicals that remain in the body can cause oxidative stress, resulting in damage that may lead to various health conditions.
Molecular docking studies have highlighted the potential of lauric acid in inhibiting protein targets involved in hyperlipidemia. Validation through in vivo studies found that the activity of key enzymes HMG-CoA reductase and lipoprotein lipase were reduced in animals fed with lauric acid and coconut oil.
Clinical Evidence: A randomized, placebo-controlled, prospective clinical trial was conducted at the Institute of Medical Research (MRI), Colombo, Sri Lanka, to investigate the lipid effects of different forms of coconut — oil, milk, and flakes — when consumed by free-living healthy subjects. The baseline and end-of-8th-week lipid profile was measured in a whole group of 190 participants. There were significant interaction effects between time and group for all response measures except for LDL. This implies that mean HDL, total cholesterol-to-HDL ratio, and non-HDL varied significantly among the three treatment groups and the control at different time points.
An eight-week study on adults consuming coconut milk porridge reported an 18% rise in HDL cholesterol. Clinical trials consistently show coconut milk raises HDL cholesterol, and the effect on LDL is less dramatic than might be expected from a food that is predominantly saturated fat.
The isocaloric replacement (by 1% of energy intake) of carbohydrates with lauric acid — the predominant fatty acid in coconut oil — increased total cholesterol by 0.029 mmol/L, LDL-cholesterol by 0.017 mmol/L, and HDL-cholesterol by 0.019 mmol/L.
Lauric acid, the main fatty acid in coconut fat, may raise LDL cholesterol by decreasing the activity of the receptors that clear LDL from the blood. Two studies on similar populations suggest that the cholesterol response to lauric acid may vary by individual and may depend on the amount in the diet. In a study in healthy women, replacing 14% of monounsaturated fats with lauric acid raised LDL cholesterol by about 16%, while replacing 4% of these fats with lauric acid in another study had very little effect on cholesterol.
Epidemiological Evidence: A recent systematic review, based on 13 observational studies, showed that consumption of coconut flesh or squeezed coconut in the context of traditional dietary patterns was not associated with adverse cardiovascular outcomes. However, due to the limitations of these observational study designs (cross-sectional, case-control), which are prone to selection bias, confounding, ecological bias, and recall bias, findings need to be interpreted with caution.
Evidence Strength: No randomized controlled trials (RCTs) and/or prospective cohort studies have investigated the effect or association of coconut oil (or milk) with cardiovascular disease endpoints. Evidence from RCTs indicated that coconut oil seems to have less detrimental effects on total and LDL-cholesterol compared to butter, but not compared to cis-unsaturated vegetable oils such as safflower, sunflower, or canola oil. Overall, the evidence on cardiovascular outcomes is preliminary and largely based on lipid surrogate markers rather than hard endpoints such as myocardial infarction or stroke. The debate around lauric acid's classification as a long-chain or medium-chain fatty acid adds further complexity to interpreting these data.
Preclinical Evidence: Lauric acid and monolaurin have been shown to have a strong ability to destroy gram-positive bacteria, especially S. aureus, fungi such as C. albicans, and viruses including vesicular stomatitis virus (VSV), herpes simplex virus (HSV), and visna virus (VV). In a study of the antimicrobial effects of lauric acid from coconuts, researchers isolated various bacterial strains and exposed them to lauric acid in a laboratory setting.
Evidence Strength: Although it is generally accepted that coconut oils containing high concentrations of lauric acid possess potential antimicrobial effects, little actual investigation has been performed using the natural product to treat superficial or systemic infections due to bacteria, viruses, or fungi. Various studies are carried out in vitro and in vivo using experimental animals such as rats, shedding light on the efficacy of lauric acid. Research on the topic emphasizes the need for further investigation to explore the efficacy of lauric acid in human health. The antimicrobial evidence is therefore predominantly preclinical (in vitro and animal), with limited human clinical data.
The authors of a 2015 study found that Malaysian coconut milk had higher antioxidant activity than milk from goats and cows. Research from 2020 concluded that the phenolic content in coconut could help protect lipids, proteins, and DNA in the body from damage due to oxidative stress. Antioxidant properties of the methanolic extracts of the coconut kernel have been tested with DPPH and ABTS assays as a function of maturity, and antioxidant activities increased up to 190 days from the date of pollination, then decreased or remained unchanged.
Evidence Strength: Most antioxidant evidence for coconut milk is in vitro or animal-based. Robust human clinical trials specifically examining coconut milk's antioxidant effects on disease outcomes are lacking.
Medium-chain triglycerides promote energy expenditure, weight loss, and lipid catabolism by improving gut microbial equilibrium and gut barrier function. Research suggests that MCTs may help reduce appetite and decrease calorie intake compared to other fats. In a small study, overweight men who consumed 20 grams of MCT oil at breakfast ate 272 fewer calories at lunch than those consuming corn oil.
Caveats: However, the small amounts of MCTs found in coconut milk are unlikely to have any significant effects on body weight or metabolism. These findings, largely derived from studies using concentrated MCT oil rather than coconut milk per se, cannot be directly extrapolated to coconut milk as a food.
Medium-chain fatty acids contained in virgin coconut oil, human milk, and infant formulae could enhance the growth of Bifidobacterium and Lactobacillus, improving metabolic and cognitive functions. The augmentation of the intestinal microbiota by the intake of phenolic compounds has been implicated in disease prevention and symptom recovery. Fermented forms of coconut milk show particular potential in this area, as the lactic acid bacteria present in fermented coconut milk can further diversify the gut flora.
Evidence Strength: Direct human trials on coconut milk's effects on gut microbiome composition are very limited. The available evidence is primarily mechanistic (based on known properties of MCFAs and phenolics) and preclinical.
Coconut oil and milk are often found in soaps, body lotions, hair oils, and cosmetics, as they are very moisturizing for the hair and skin. Findings indicate that lauric acid has antimicrobial and anti-inflammatory properties, suggesting it may help support immune responses relevant to skin health. Human clinical evidence specifically for topical coconut milk (as opposed to coconut oil) in dermatological conditions is limited in the peer-reviewed literature.
There is no established pharmacopeial monograph or officially approved therapeutic dose for coconut milk as a dietary supplement. The following dosages have been reported or implied in scientific studies:
Despite the low prevalence of IgE sensitivity to fresh or boiled coconut milk and coconut oil, those preparations may contain allergens of which the clinical significance remains undetermined. A clinical study included 18 patients with immediate hypersensitivity to coconut milk, including five who developed anaphylaxis. Previous studies have reported allergic reactions following consumption of coconut; milk, cream, oil, and water containing food. A recent Australian pediatric case series has reported 35 patients with type 1 hypersensitivity to coconut, including 9 patients with anaphylaxis to coconut milk, coconut cream, baked coconut, and coconut water. Twelve dietary allergens of coconut milk and oil, ranging from 5 to 128 kDa, were identified in one immunological study. Fresh coconut milk and boiled coconut milk were found to be highly allergenic, whereas unrefined coconut oils had mild allergenicity.
The American Heart Association reviewed seven controlled trials on coconut oil and found it raised LDL cholesterol in all seven, significantly in six. Their official position is to advise against using coconut oil because it increases LDL cholesterol, a known driver of atherosclerosis, with "no known offsetting favorable effects." While these trials focused on coconut oil rather than coconut milk, the high overlapping lipid content between the two is relevant. While observational evidence suggests that consumption of coconut kernel or squeezed coconut milk in the context of traditional dietary practices does not lead to adverse cardiovascular outcomes, intervention studies have found that lowering the intake of dietary saturated fat can alter lipid profiles.
Controversy exists as to the classification of lauric acid as either a long-chain or a medium-chain fatty acid. All saturated fatty acids are not the same where lipidogenicity is concerned. Long-chain fatty acids are well established as being lipidogenic, whereas medium-chain saturated fatty acids are thought to be neutral in this aspect. This debate has direct implications for interpreting the cardiovascular safety data.
Full-fat coconut milk contains 230 kilocalories per 100 ml, making it one of the most calorie-dense non-alcoholic beverages. Regular high-volume consumption may contribute meaningfully to total caloric intake.
Commercial coconut milk beverages may contain added sugars or emulsifiers (such as guar gum) that can cause gastrointestinal symptoms in susceptible individuals, particularly those with irritable bowel syndrome (IBS) or fructose malabsorption. This concern is most applicable to sweetened or fortified commercial preparations rather than pure extracted coconut milk.
No well-documented pharmacokinetic drug interactions specific to coconut milk have been reported in peer-reviewed literature at the time of writing. The high fat content of coconut milk may in principle influence the absorption of fat-soluble substances, but no specific clinically significant interactions with medications have been established from human clinical data.
Though coconut milk is used for cooking in many countries on a daily basis as a major source of dietary fat, its nutritional composition has not been sufficiently investigated with respect to microbial safety in traditional preparation contexts. Fresh, non-pasteurized coconut milk has a short shelf life due to its high fat and water content, and improper storage can lead to microbial spoilage.
Health conditions that Coconut milk may help support.
Coconut milk contains polyphenols, tocopherols, and phytosterols that neutralize reactive oxygen species and inhibit lipid peroxidation. A PMC study confirmed that both domestic and commercial coconut milk preparations possess measurable antioxidant activity. VCO polyphenols showed concentration-dependent protection against UVB-induced intracellular ROS in human keratinocyte models.
MCTs in coconut milk have been shown in controlled trials to reduce subsequent energy intake over 48 hours, likely via delayed gastric emptying and elevated ketone levels rather than classical appetite hormone modulation. A 2020 systematic review confirmed MCTs decrease energy intake compared to long-chain triglycerides, though effects on subjective appetite ratings are inconsistent.
Coconut oil pulling has been studied in a randomized controlled pilot trial for its effects on halitosis, showing reductions in odor-causing oral microorganisms. The antimicrobial properties of lauric acid reduce the bacterial load responsible for volatile sulfur compound production, which underlies bad breath.
The fat content of coconut milk—primarily MCTs—slows gastric emptying and delays starch digestion via amylose-lipid complex formation, blunting postprandial blood glucose responses. Animal and limited human data support a modest glycemic-moderating effect, though direct clinical trials in humans with coconut milk specifically are limited.
Lauric acid and caprylic acid—the key medium-chain fatty acids in coconut milk—have demonstrated anticandidal activity in vitro, disrupting Candida albicans cell membranes and inhibiting biofilm formation. In vitro studies show inhibition zones comparable to standard antifungal drugs. Human clinical evidence is limited but in vitro and mechanistic data are robust.
A randomized trial of 60 healthy adults found 8 weeks of coconut milk porridge consumption significantly reduced LDL cholesterol and raised HDL cholesterol. A separate Cambridge RCT confirmed coconut oil did not raise LDL versus olive oil and significantly raised HDL. The American Heart Association notes concern that coconut-derived saturated fat can raise LDL in some contexts, indicating mixed but genuine clinical evidence.
Virgin coconut oil (derived from coconut milk) contains polyphenols and MCFAs that inhibit pro-inflammatory cytokines (TNF-α, IL-6, IL-8) in vitro and reduce inflammation markers in animal models. A pharmacology study found VCO at 80 mg/kg showed 74% inhibitory effect on chronic inflammation in rodents. Human evidence remains largely indirect via CRP reductions observed in coconut oil trials.
MCTs from coconut oil are converted to ketone bodies, which provide an alternative brain fuel bypassing impaired glucose metabolism in Alzheimer's disease and cognitive aging. Multiple human studies of MCT oil have reported improvements in memory and cognition in mild cognitive impairment and Alzheimer's, and a 2025 Frontiers in Nutrition preclinical study found coconut-derived MCTs reduced amyloid-β, neuroinflammation, and memory deficits in an AD mouse model.
Topical application of virgin coconut oil—pressed from coconut milk—has demonstrated efficacy comparable to mineral oil for treating dry skin in clinical studies. It reduces transepidermal water loss (TEWL) and provides barrier protection for the stratum corneum. Clinical studies have shown VCO improves skin hydration and moisture markers.
Virgin coconut oil has been tested against mineral oil in atopic dermatitis (eczema) patients and demonstrated superior outcomes in clinical review. VCO's anti-inflammatory mechanisms (cytokine inhibition, skin barrier repair) are relevant to eczema pathophysiology. A 2022 review confirmed coconut oil outperformed mineral oil in atopic dermatitis trials.
MCTs in coconut milk are converted rapidly to energy in the liver or to ketone bodies, providing a faster-acting fuel source than long-chain dietary fats. This makes coconut milk a source of rapidly accessible energy, particularly relevant in low-glucose or ketogenic metabolic states.
Coconut oil (derived from coconut milk) has demonstrated antifungal activity against dermatophytes and Candida species in vitro, with lauric acid disrupting fungal cell membranes. A JETIR review (2023) confirmed VCO's viability as a topical antifungal against skin and nail fungal infections. Clinical human studies are limited but in vitro mechanistic evidence is robust.
Oil pulling with coconut oil—a practice using its fat fraction—has been tested in clinical trials and shown to reduce plaque, gingivitis scores, and Streptococcus mutans counts in saliva. A 2020 systematic review (PMC) concluded that oil pulling with coconut oil may have a beneficial effect on oral health, though evidence quality is mixed.
Coconut milk's MCFAs, particularly lauric acid, exert selective antimicrobial effects against pathogenic bacteria and Candida in the gut while being free of lactose. Animal data show MCTs from coconut oil increase beneficial Akkermansia abundance and reduce intestinal permeability. Additive-free coconut milk is documented as gut-friendly for individuals intolerant to dairy.
MCTs in coconut milk are metabolized differently from long-chain fats, being rapidly oxidized in the liver and promoting greater energy expenditure (approximately 16% higher thermogenesis vs. LCTs). Animal studies and some human MCT trials show reduced body fat and waist circumference, though high-quality RCTs specific to coconut milk as a whole food are limited.
Clinical evidence on coconut milk and cardiovascular outcomes is primarily indirect, operating through lipid biomarkers. Coconut milk's MCFAs raise HDL and may promote reverse cholesterol transport, but epidemiological data also show frequent coconut milk intake (>3x/week) was associated with a 1.3-fold increased vascular disease risk. The evidence is genuinely mixed and no long-term cardiovascular endpoint trials exist specifically for coconut milk.
Coconut milk is inherently lactose-free, making it a well-documented and clinically recognized dairy alternative for individuals with lactose intolerance. Its use avoids the gastrointestinal symptoms (bloating, gas, diarrhea) associated with lactose malabsorption, and it is nutritionally viable as a dairy substitute in cooking and beverage contexts.
The MCTs in coconut milk are absorbed and metabolized faster than long-chain fats, transported directly to the liver and rapidly oxidized for energy or converted to ketones. This unique pathway increases diet-induced thermogenesis by approximately 16% compared to long-chain triglycerides, making coconut milk metabolically distinct from most dietary fats.
Animal studies show topical VCO (coconut oil from coconut milk) increases collagen, elastin, and glycosaminoglycan synthesis in skin. In vitro studies confirm VCO enhances MMP-9, PDGF-BB, and TGF-beta-1 expression—proteins involved in collagen remodeling and extracellular matrix production. Human clinical data are limited.
The MCTs in coconut milk increase diet-induced thermogenesis by approximately 16% compared to long-chain triglycerides due to their direct hepatic oxidation and higher metabolic heat production. A peer-reviewed analysis (Ingale et al., Journal of Food Science, 1999) established this thermogenic difference, and multiple reviews have confirmed that MCT metabolism is more thermogenic than LCT metabolism.
Lauric acid in coconut milk is converted in vivo to monolaurin, which disrupts the lipid bilayer envelopes of lipid-coated viruses, impairing their replication. In vitro studies confirm antiviral activity against multiple enveloped viruses. Human clinical evidence is limited, but the mechanism is well-characterized in virological literature.
A 2024 systematic review of in vivo studies (excisional, burn, and diabetic wound models) found all four qualifying studies demonstrated that VCO promotes wound healing, attributed to its anti-inflammatory, antioxidant, and antibacterial properties. Animal studies show faster epithelialization and increased collagen synthesis with VCO. Human clinical data are currently limited to no available trials.
Traditional use of coconut and coconut milk for anti-yeast and cleansing protocols is documented in tropical medicine traditions across South and Southeast Asia. Modern functional and integrative medicine has adopted coconut oil and milk as dietary interventions in Candida management protocols, supported by in vitro antimicrobial evidence rather than controlled human trials.
Coconut milk has a long traditional history of topical use in South and Southeast Asian cultures for skin moisturization and anti-aging. Its fatty acids support skin barrier function and reduce TEWL. While VCO clinical studies confirm skin hydration benefits and some collagen-supportive effects in wound healing models, direct human RCT evidence for anti-wrinkle outcomes is absent.
Body systems that Coconut milk may help support.
Go back